INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2005

Daily intake of a 25 g flaxseed muffin reduced tumor proliferation and c-erbB2 expression while increasing apoptosis in postmenopausal breast cancer patients.

Postmenopausal patients with newly diagnosed breast cancer were randomized to consume a 25 g flaxseed-containing muffin (n = 19) or a control placebo muffin (n = 13) daily between diagnosis and surgery. The flaxseed group showed significant reductions in Ki-67 labeling index (34.2%; P = 0.001) and c-erbB2 expression (71.0%; P = 0.003), along with an increase in apoptosis (30.7%; P = 0.007), which were not observed in the placebo group. Mean urinary lignan excretion increased by 1,300% (P < 0.01) in the flaxseed group compared with placebo. Total flaxseed intake correlated with changes in c-erbB2 score (r = -0.373; P = 0.036) and apoptotic index (r = 0.495; P < 0.004).

Study type
Randomized double-blind placebo-controlled trial
Who was studied
32 postmenopausal patients with newly diagnosed breast cancer (19 flaxseed, 13 placebo)
What was measured
Ki-67 labeling index, apoptosis, c-erbB2 expression, estrogen and progesterone receptor levels, and urinary lignan excretion

THE PAPER

Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer.

Thompson LU, Chen JM, Li T, Strasser-Weippl K, Goss PE. Clin Cancer Res, 2005.

PubMed 15897583 ↗DOI 10.1158/1078-0432.ccr-04-2326 ↗

Cancer

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.